Denosumab-Mepha osteo 60 mg/ml, Injektionslösung in einer Fertigspritze

7680700660013 CH-70066 Injektionslösung

Associated product:

DENOSUMAB MEPHA osteo 60 mg/ml sol inj 60 mg 1 pce

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/12/2025
Patient information leaflet
Français
01/12/2025
Patient information leaflet
Italien
01/12/2025
Summary of Product Characteristics
Allemand
01/12/2025
Summary of Product Characteristics
Français
01/12/2025
Summary of Product Characteristics
Italien
01/12/2025

Detailed composition

Substance Quantity Type Category
denosumabum
60.0 MG Substance Wirkstoff (Principe actif)
natrii acetas trihydricus
- Substance HNIDK
natrium
0.29 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
sorbitolum
47.0 MG Substance HBESI
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 206.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2026

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
70066
Drug name
Denosumab-Mepha osteo, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
M05BX04
Authorization status
Z
Dispensing category
B
First authorization
26/11/2025
Authorization expiration date
25/11/2030
IT Number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Package details

Description (FR)
DENOSUMAB MEPHA osteo 60 mg/ml sol inj 60 mg 1 pce
Description (DE)
DENOSUMAB MEPHA osteo 60 mg/ml Inj Lös 60 mg 1 Stk
Market launch
01/02/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data